Introduction 56
Programmed cell death-1 (PD-1) is an immunoinhibitory protein that is expressed on lymphocytes 57 following the engagement of their antigen specific receptor (1) . During the course of an acute 58 infection, PD-1 expression is transient on the surface of CD8 T cells, peaking during the height of 59 an infection and returning to near baseline levels in the resulting memory T cell pool (1) (2) (3) (4) (5) . During 60 chronic exposure to antigen, such as that from a chronic viral infection or in certain cancers, PD-61 1 expression is sustained at high levels and a state of T cell exhaustion is induced that is 62 characterized by severe curtailment in effector functions, including the ability to proliferate, 63 produce cytokines, and carry out cytotoxic responses (6). T cell exhaustion is in part mediated 64 by signaling through PD-1's intracellular tyrosine immunoinhibitory domains following PD-1's 65 surface engagement with its ligands PD-L1 or PD-L2 on target cells (1, (7) (8) (9) . Although antibody 66 blockade of PD-1/PD-L1 interactions can temporarily reinvigorate immune function from the 67 exhausted state (1) , PD-1 remains stably expressed on T cells during a chronic infection (10), 68 and is expressed even upon removal of the cell from a chronic stimulatory environment (11). The 69 stability of PD-1 expression and inhibition of effector functions across generations of cell division 70
suggests that an epigenetic program stably regulates the transcriptional state of the Pdcd1 locus. 71 PD-1 is encoded by the Pdcd1 gene. In CD8 T cells, Pdcd1 is regulated by the direct 72 actions of transcription factors and epigenetic mechanisms (2, 10, 12) . Upon T cell receptor 73 engagement, Pdcd1 is directly activated by a combination of transcription factors (NFATc1 and 74 AP-1) that bind to a series of promoter proximal elements termed Conserved Regions (CR)-B and 75 CR-C (12, 13), respectively. NFAT also binds to sites at -3.7 and +17.1 kb with respect to the 76 transcription start site (14) . Additional transcription factors appear to sustain Pdcd1 during chronic 77 infection and include the binding of NUR77 and FOXN1 to sites located at -23 kb and CR-C, 78 respectively (15) (16) (17) (18) . Cytokine stimulation that results in STAT3 and STAT4 activation can further 79 induce or sustain Pdcd1 expression in mouse CD8 T cells by binding to the distal -3.7 and +17. 1 80 sites (14) . Following the cessation of the TCR signaling (e.g., via antigen/viral clearance), Pdcd1 81 is silenced through the binding of B lymphocyte induced maturation protein-1 (Blimp-1) to a region 82 between CR-C and CR-B (19). Blimp-1 binding results in the eviction of NFATc1 from . 83
In addition to these mechanisms, epigenetic regulation through DNA methylation occurs across 84 CR-C and near CR-B in CD8 T cells in both mice and humans (2, 10). In naïve CD8 T cells, CpGs 85 in the above DNA regions are consistently methylated. Upon CD8 T cell activation, the 86 methylation is lost in a time course that parallels Pdcd1 expression. In an acute infection setting, 87 the locus is remethylated as the infection is cleared and PD-1 levels return to the baseline as 88 mentioned above. By contrast, during chronic infection, DNA methylation is permanently lost and 89 is not regained (2, 10 Blimp-1 is also expressed during a chronic infection in exhausted CD8 T cells where PD-1 levels 100 are at their highest, yet fails to repress PD-1 (21). The molecular mechanism for how Blimp-1 101 could function to repress Pdcd1 exclusively following acute inflammation is not fully clear. 102
As a repressor, Blimp-1 is known to recruit additional transcriptional repressors that result 103 in silencing the local chromatin environment (22) (23) (24) . Along with histone deacetylases HDAC1 104 and HDAC2 and the histone methyltransferase G9a, Blimp-1 can recruit the lysine-specific 105 demethylase 1a (LSD1) encoded by . LSD1 catalyzes the removal of mono and 106 dimethylation modifications of H3K4 that are associated with transcriptional activation (26-28), 107 thereby facilitating an epigenetic state of gene silencing. Given the ability of Blimp-1 to repress 108 genes through recruitment of histone modifiers such as LSD1, we set out to test the hypothesis 109 that LSD1 contributes to the regulation of Pdcd1 in a Blimp-1-dependent manner. Indeed, we 110 found that Blimp-1 was necessary to recruit LSD1 to the Pdcd1 locus, and that when bound, LSD1 111 actively down-regulates PD-1 transcription and expression. Furthermore, we found that Blimp-1 112 was bound to the Pdcd1 locus in both acute and chronic settings; however, LSD1 was only 113 recruited following an acute stimulation, correlating with removal of proximal H3K4 Chromatin immunoprecipitation (ChIP) assays were performed as previously described (19, 35) . 171
Briefly, purified cell populations were crosslinked for 10 minutes in 1% formaldehyde, and 172 subsequently lysed in cell lysis buffer (5mM PIPES pH 8.0, 85 mM KCl, 0.5% NP-40). Chromatin 173 was extracted using nuclei lysis buffer (50 mM TRIS pH 8.1, 10 mM EDTA, 1% SDS) and 174 sonicated to an average length of 400-600 bp.
Chromatin ( 
DNA methylation analysis 182
The DNA methylation content of the CR-B associated region was determined by clonal bisulfite 183 sequencing as previously described (2). Briefly, genomic DNA purified from CD8 T cells and 184 bisulfite converted using the EpiTect Bisulfite Kit as per the manufacturer's instructions (Qiagen, 185 Inc.). Bisulfite-converted DNA was PCR amplified and cloned with the TOPO TA cloning kit (Life 186 Technologies). Clones were isolated and the plasmid DNA regions were sequenced and changes 187 in CpG DNA methylation were determined. Data were aligned in silico using the R / Bioconductor 188 Biostrings package and custom scripts as previously described (36). A Fisher exact test was 189 used to determine significance. 190
191

Results: 192
Pdcd1 histone modifications differ between acute and chronic infection 193
As previously shown (1, 2) , infection with LCMV Armstrong induces an acute infection that results 194 in CD8 T cells expressing high surface levels of PD-1 on day 5 post-infection, but this ultimately 195 decreases to near naïve T cell levels 8 days following infection when virus is no longer detectable 196 (Fig.1A) . Conversely, infection with the chronic LCMV strain Clone-13 results in PD-1 surface 197 (Fig. 1A ) and mRNA levels (2) that remain elevated during the course of the infection. To gain 198 additional insight into epigenetic mechanisms that may be driving the above changes and 199 differences in PD-1 expression between acute and chronic infections, we examined activating 200 and repressive histone modifications at key regulatory elements (37) across the Pdcd1 locus ( The above data raise the question as to whether active histone marks examined appear 216 at an earlier timepoint during an in vivo response to an Armstrong infection that would correlate 217 with the increased surface expression. To test this, cells were isolated at day 5 following LCMV 218
Armstrong infection, a time point in which PD-1 expression was high (Fig. 1A) and enough 219 activated CD8 T cells (CD44 hi CD62L low ) could be isolated for ChIP. In these experiments, 220 H3K4 me2 and H3K27 ac were enriched over control naïve CD8 T cells at all four key regulatory 221 elements; whereas H3K4me1 was only significantly enriched at -3.7 and 17.1 (Fig 1D) and LcKO mice were purified and stimulated in culture using aCD3/CD28 beads over a 4-day 239 period and expression of Pdcd1 mRNA was measured by qRT-PCR at daily intervals. CD8 T 240 cells from LcKO animals displayed significantly higher levels of Pdcd1 mRNA compared to WT 241 littermate controls at 24 hours, the peak of Pdcd1 expression by this method of stimulation (Fig.  242   2A) . Moreover, whereas WT Pdcd1 mRNA levels decayed over the 96 h time course, Pdcd1 243 mRNA levels remained significantly higher in the LcKO CD8 T cells at all time points after initial 244 stimulation. Additionally, qRT-PCR for Kdm1a mRNA levels showed that the LcKO animals had 245 a significant reduction in LSD1 mRNA compared to WT controls, confirming efficient deletion of 246 the floxed Kdm1a alleles following stimulation (Fig. 2B) . The lag phase prior to complete deletion 247 of Kdm1a may account for the slight, although significantly less than in WT, decrease in Pdcd1 248 expression after peak. These results demonstrate that LSD1 acts as a negative regulator of PD-249 1 expression in CD8 T cells following ex vivo stimulation. 250
251
LSD1 represses PD-1 following acute viral infection 252
To test if PD-1 expression is modulated by LSD1 during an acute viral infection, WT and LcKO 253 mice were infected with LCMV Armstrong and PD-1 expression on LCMV antigen-specific CD8 T 254 cells was monitored by flow cytometry. At day 8 post infection, when viral loads have been cleared 255 and WT mice have down-regulated surface PD-1 expression on LCMV antigen-specific CD8 T 256 cells (Fig. 3A, blue) , LcKO CD8 T cells retained high levels of PD-1 expression (Fig. 3A red) . 257
Previously (19), we found that conditional deletion of Blimp-1, a transcriptional repressor that has 258 been suggested to interact with LSD1 (23), produced a similar phenotype to LcKO mice, which is 259 reconfirmed here (Fig. 3A) LSD1 knockout antigen-specific CD8 T cells no longer showed an increase in PD-1 expression, 263 unlike cells from Blimp-1 knockout mice, which still showed some level of PD-1 expression over 264 their littermate (Cre -) controls (Fig. 3A) . This suggests that while LSD1 is an important 265 determinant in the pathway responsible for decreasing PD-1 expression it does not account for 266 the entire level of PD-1 repression mediated by To determine if LSD1 affected PD-1 expression during a chronic LCMV infection, antigen 268 specific cells were isolated from WT and LcKO mice following LCMV Clone-13 infection and 269
analyzed by flow cytometry. At day 8, WT and LcKO CD8 T cells expressed moderate levels of 270 PD-1 (Fig. 3B ), while at day 28 post infection, no difference in MFIs were observed between WT 271
and LcKO (Fig. 3, bottom) . During chronic infection, BcKO CD8 T cells at day 8 had an overall 272 mean fluorescent intensity that was higher, but the histogram patterns overlap with WT cells to a 273 significant degree. Thus, at this early stage, Blimp-1 may not be contributing to Pdcd1 regulation. 274
At the chronic infection time point (day 28), BcKO CD8 T cells expressed slightly lower levels of 275 PD-1, which was in agreement with previous reports (21). The differential roles performed by 276
Blimp-1 and LSD1 at day 28 of a chronic infection may indicate that their activities may be 277 dissociated under these conditions and at these late time points. 278 279
Blimp-1 recruits LSD1 to Pdcd1 280
To determine if LSD1 interacts directly with the Pdcd1 locus concurrent with PD-1 down-281 regulation, and whether it is recruited there by Blimp-1, ChIP was performed on ex vivo 282 aCD3/CD28 stimulated splenic CD8 T cells isolated from LcKO and BcKO animals, as well as the 283 corresponding Cre -controls (WT). At day 4, when PD-1 expression has nearly returned to 284 baseline levels ( Fig. 2A) , LSD1 was bound to the CR-B region in WT mice (Fig. 4A) . This indicates 285 a direct interaction with the locus and suggests that LSD1 itself directly represses Pdcd1 286 transcription. However, LSD-1 binding was not observed in BcKO mice concurrent with a loss of 287
Blimp-1 at the Pdcd1 locus (Fig. 4A, B) , indicating that Blimp-1 is necessary to recruit LSD1 to 288 the region. Importantly, LSD1 binding was minimally observed at the locus in LcKO cells, 289 indicating that the conditional deletion was efficient (Fig. 4A) . However, Blimp-1 was still bound 290 in LcKO mice (Fig. 4B) 
LSD1 interacts with Pdcd1 following an acute but not chronic infection 295
Blimp-1 binds directly to Pdcd1 following an acute infection, and acts as a transcriptional 296 repressor (19). However, during a chronic infection, Blimp-1 is expressed at even higher levels, 297 and was correlated with maximal PD-1 expression (21). To determine if Blimp-1 interacted directly 298
with Pdcd1 during chronic inflammation in vivo, ChIP was performed on virus-specific CD8 T cells 299 from naïve, day 8 acutely-infected (Armstrong), or day 8 chronically-infected (Clone-13) mice. As 300 we previously reported, Blimp-1 was bound to Pdcd1 following acute infection (19). LSD1 was 301 also bound, correlating with its repressive role (Fig. 5A ). Blimp-1 was also bound at day 8 during 302 a chronic infection (Fig. 5A) . Importantly, in this setting, LSD1 was not recruited to the region 303 even though Blimp-1 was bound. To rule out the possibility of differential expression levels of 304 LSD-1 between viral infections, we analyzed previously published (39) RNA microarray data and 305 observed no differences (Fig. 5B ). This suggests that although Blimp-1 interacts with the Pdcd1 306 locus in CD8 T cells during a chronic infection setting, it fails to down-regulate PD-1 levels 307 because LSD1 is not recruited. 308
309
LSD1 is responsible for the decommissioning of Pdcd1 enhancer elements. 310
As LSD1 is responsible for removing the histone marks H3K4 me1 and H3K4 me2 , we set out to 311 determine if LcKO mice possessed increased levels of these marks at the Pdcd1 locus. To test 312 this, LcKO and Cre -control (WT) mice were infected with LCMV Armstrong for 8 days. Antigen 313 specific (pooled gp33, gp276, np396) CD8 T cells were isolated by FACS and subjected to ChIP 314 for H3K4 me1 and H3K4 me2 at key regulatory regions across the Pdcd1 locus. CD8 T cells from 315 LcKO mice showed enrichment for H3K4 me1 at the -3.7 and +17.1 regions compared to WT cells 316 (Fig. 5C ). Enrichment for H3K4 me2 was also observed in the LcKO CD8 T cells at the CR-B, CR-317 C, and -3.7 regulatory elements. The increased levels of these active histone marks correlated 318 with the elevated levels of PD-1 expressed by LcKO CD8 T cells and mirrors the histone pattern 319 observed in the PD-1 expressing cells at day 8 during chronic infection (Fig. 1C) . Together, these 320 results demonstrate that LSD1 is responsible for removing the activating histone marks H3K4 
Epigenetic silencing of the locus following acute infection is enforced by LSD1 326
We previously showed that during the course of LCMV Armstrong infection antigen specific CD8 327
T cells initially lose CpG methylation at a region near CR-B (2). As the infection wanes and PD-328
1 levels return to near baseline, DNA methylation in that region reappears. Thus, loss of CpG 329 methylation at the Pdcd1 locus is correlated with gene expression, and reappearance of 330 methylation is concurrent with gene silencing. Since de novo DNA methylation is dependent on 331 an H3K4 me0 methylation state (40, 41) and LSD1 has been shown to catalyze the removal of 332 H3K4 me1 and H3K4 me2 (Fig. 5C ), as well as being important for global DNA methylation (42), we 333 sought to determine if remethylation of the Pdcd1 was altered in LcKO mice during an acute 334 infection. In accordance with the remethylation observed in WT animals at day 8 after LCMV 335
Armstrong infection (2), WT control mice showed a relative abundance of CpG methylation across 336 the CR-B region of Pdcd1 (Fig. 6) . In contrast, LSD1-deficient CD8 T cells, which have elevated 337 levels of PD-1 expression at this time (Fig. 3) , showed minimal remethylation of the locus with a 338 majority of alleles analyzed exhibiting either no methylation or only a handful of methylated CpGs 339 across the region (Fig. 6 ). This suggests that the inability to remove H3K4 methylation in LSD1-340 deficient CD8 T cells inhibits the acquisition of DNA methylation, which leads to a failure to fully 341 silence PD-1, thereby providing a further mechanism for retaining prolonged gene expression. BcKO mice showed increased PD-1, suggesting an inhibitory function, the same deletion resulted 391 in modestly lower levels of PD-1 in a chronic infection, suggesting Blimp-1 acted as an activator. 392
In this study, Blimp-1 was shown to be bound at Pdcd1 in both infection modalities, thereby 393 precluding the possibility that the changing function of Blimp-1 was mediated indirectly through 394 binding to other target genes. Instead, recruitment of LSD1, which was dependent on the 395 presence of Blimp-1, was found to be unique to acute infections. 396
Many mechanisms could potentially explain the failure of Blimp-1 to recruit LSD1 in a 397 chronic infection setting. Splice variants of Blimp-1 have been shown both to be involved in 398 different timing of expression (49) by magnetic separation and subject to ChIP to assess LSD1 and Blimp-1 binding. Naïve CD8 T 650 cells were also magnetically isolated (See Methods) from uninfected mice were used as a control, 651
as was an a-IgG antibody. Blimp-1 binding was assessed at the Blimp-1 binding site (Fig 1B) of 652 the Pdcd1 locus and LSD1 binding was assessed at CR-B. (B) Microarray RNA expression data 653 from (39) was analyzed for Kdm1a expression (LSD1). (C) LcKO and littermate control WT mice 654 were infected with LCMV Armstrong. At day 8, gp33-, gp276-, and np396-specific CD8 T cells 655 were isolated, pooled, and subjected to ChIP with a-H3K4 me1 and H3K4 me2 antibodies at the 656 indicated regions of the Pdcd1 locus. Three independent biological replicates were assayed. A 657 two tailed Student's t test was used to determine statistical significance between samples. *, P 658 < 0.05 ***, P < 0.001. 659 660 6   167  273  278  309  333  410  449  454  480  167  273  278  309  333  410  449  454  480  167  273  278  309  333  410  449  454 
